十亿最贫困人口的内在心血管疾病
Gene F Kwan1, Bongani M Mayosi2, Ana O Mocumbi2
1From Department of Medicine, Boston University School of Medicine, MA (G.F.K.); Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA (G.F.K., G.B.); Partners In Health, Boston, MA (G.F.K., G.B.); Department of Medicine, Groote Schuur Hospital and University of Cape Town, South Africa (B.M.M.); Universidade Eduardo Mondlane and the Instituto Nacional de Saúde, Maputo, Mozambique (A.O.M.); Department of Medicine, School of Medicine Universidad Peruana Cayetano Heredia, Lima, Peru (J.J.M.); CRONICAS Center of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru (J.J.M.); MRC-PHE Centre for Environment and Health, and Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, UK (M.E.); Jan Swasthya Sahyog, Village and Post Ganiyari, Bilaspur (Chhattisgarh), India (Y.J.); Oxford Department of International Development, University of Oxford, UK (G.R.); Department of Epidemiology, Boston University School of Public Health, MA (E.J.B.); Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, MA (S.V.S.); and Division of Global Health Equity, Brigham and Women's Hospital, Boston, MA (G.B.). genekwan@bu.edu.
最贫困10亿人口的心血管疾病与高收入国家有很大差异,非缺血性疾病和较年轻的疾病普遍存在. 目前的全球CVD目标需要扩大以有效应对这些独特的挑战.
科学领域:
- 全球健康
- 流行病学
- 心血管医学
背景情况:
- 在低收入和中等收入国家,特别是农村地区,心血管疾病 (CVD) 数据往往很少.
- 与高收入国家相比,最贫穷的人群表现出明显的心血管疾病特征,非动脉样硬化病的患病率更高.
研究的目的:
- 总结世界上最贫困人口中心血管疾病的流行病学.
- 评估当前全球心脏病控制目标对这些服务不足的群体的相关性.
主要方法:
- 对16个最贫困国家的初级数据来源和2013年全球疾病负担研究估计的分析.
- 在最贫困和高收入国家之间比较心脏病负担,风险因素和年龄分布.
主要成果:
- 在最贫穷的国家,缺血性心脏病仅占心脏病残疾调整后寿命年数的12%,而在高收入国家,这一比例为51%.
- 仅有53%的心脏病负担与行为/代谢风险有关,而高收入国家则为85%.
- 在最贫困国家,34%的心脏病负担发生在30岁以下的个人身上,而高收入国家则为3%.
结论:
- 目前全球非传染性疾病和心血管疾病目标对最贫困人口来说不足.
- 需要采取补充策略,应对年轻发病,环境/传染性风险和综合卫生系统,包括对先天性和类风湿性心脏病的心脏手术.
更多相关视频
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
06:35Author Spotlight: Insights into Cardiometabolic Diseases with Subcutaneous Adipose Tissue Microvasculature Studies
Published on: April 5, 2024
相关概念视频
Cardiovascular Drugs: Classification based on Therapeutic Indications
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Coronary Artery Disease III: Clinical Manifestations
Endocarditis II: Clinical Features of Infective Endocarditis
